The US Food and Drug Administration is planning to hold a public hearing on issues that would help advance the development of medical products, including medical devices, drugs and biologics, used in the prevention, diagnosis and treatment of neglected tropical diseases1.
At the event, scheduled to take place on 22 September, the FDA will seek feedback from stakeholders on issues relating to pre-clinical studies, trial design, regulatory approaches and optimal solutions for neglected tropical diseases...
Please Login to read the full article.
